Key result
Chronic mitral valve insufficiency is linked to ~128% higher ESVI in moderate canine heart failure.
Why the study?
Does chronic mitral valve insufficiency cause systolic dysfunction and inadequate hypertrophy in small and large breed dogs?
Case-Control (n=105)
No
Does chronic mitral valve insufficiency cause systolic dysfunction and inadequate hypertrophy in small and large breed dogs?
Dogs with moderate heart failure from chronic mitral valve insufficiency exhibit systolic dysfunction and inadequate left ventricular hypertrophy.
Answers are grounded in this paper and cite their sources.
Suggests systolic dysfunction in moderate canine heart failure from mitral valve disease; extends findings to small breeds but needs prospective confirmation.
Background: Systolic dysfunction associated with chronic mitral valve insufficiency (CMVI) has been demonstrated in experimental animal models and large breed (LB) dogs but has been reported as an uncommon finding in small breed (SB) dogs with naturally occurring disease. It has been suggested the myocardial failure could be, in part, because of an insufficient increase in left ventricular mass. Hypothesis: To test if SB and LB dogs with CMVI and moderate heart failure have systolic dysfunction and if they have adequate eccentric hypertrophy. Animals: Data from 38 SB and 18 LB dogs affected with CMVI were compared retrospectively with results from 2 groups of normal dogs (17 SB and 32 LB) Methods: Systolic function was investigated echocardiographically by using percentage fractional shortening (FS), the ratio between observed and expected end-systolic diameter (ESD/ESDe), and end-systolic volume index (ESVI). Left ventricular hypertrophy was estimated by using the ratio between the thickness of the left ventricular free wall and the radius in diastole (h/R). Results: Both affected SB and LB dogs had a significantly increased FS and ESVI (FS% SB 45.6 + 8.04 versus 40.06 + 8.9, P < .05; FS% LB 33.64 + 8.61 versus 27.3 + 7.3 P < .05; ESVI SB 30.0 ± 2.3 mL/m2 versus 21.18 ± 13.9 mL/m2, P < .05; ESVI LB 83.22 ± 43.84 mL/m2 versus 36.43 ± 13.30 mL/m2 versus P < .001). The h/R in affected animals was decreased (0.53 ± 0.11 versus 0.41 ± 0.12, P < .05 SB; 0.47 ± 0.11 versus 0.38 ± 0.09, P < .05, LB). Conclusions and Clinical Importance: Data from this study indicate that dogs with moderate heart failure caused by CMVI have systolic dysfunction. Inadequate hypertrophy of the left ventricle may be, in part, responsible for this finding.
No takes yet. Share an insight, caveat, or question.
Borgarelli et al. (2007) conducted a case-control in Chronic mitral valve insufficiency (CMVI) (n=105). Chronic mitral valve insufficiency vs. Normal dogs was evaluated on End-systolic volume index (ESVI) in large breed dogs (83.22 ± 43.84 vs 36.43 ± 13.30 mL/m2, p=<0.001). Dogs with moderate heart failure caused by chronic mitral valve insufficiency had significantly increased end-systolic volume index and decreased h/R ratio compared to normal dogs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: